Getinge will acquire High Purity for as much as $370M to bolster biopharma business

The acquisition is aimed at strengthening Getinge’s position in the fast-growing area of custom single-use solutions for bioprocessing applications.

By Peter Green • May 31, 2023

MedTech Europe sets out position on cybersecurity, making case for reliance on MDR

As the number of connected medical devices grows, the industry group argues that Europe’s new medtech regulations should remain “the primary avenue” for medical device cybersecurity.

By Nick Paul Taylor • Updated June 12, 2023

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Microrobots powered by ultrasound show progress in drug delivery experiments in mice

Potential applications of the technology include the treatment of painful bladder syndrome, a condition that is currently managed with multiple injections.

By Nick Paul Taylor • May 31, 2023

Titan licenses robotic surgery intellectual property to Intuitive after failing to find buyer

After failing to bring its surgical robot to market and getting kicked off the Nasdaq, Titan is now marketing its intellectual property.

By Nick Paul Taylor • May 30, 2023

Friday Q&A: Stanford Biodesign’s Makower on expediting Medicare coverage for breakthrough devices

The director and co-founder of the Stanford Byers Center for Biodesign has been urging CMS to get patients access to breakthrough devices.

By Susan Kelly • Updated May 26, 2023

Boston Scientific cancels $230M stent deal after regulators erect barriers to acquisition

The Federal Trade Commission said Boston Scientific took the action in response to investigations by its staff and overseas enforcement partners.

By Nick Paul Taylor • May 26, 2023

Abbott’s remote heart failure monitoring system reduces hospitalizations in clinical trial

The study is the third randomized, controlled trial globally to link CardioMEMS to a significant health benefit.

By Nick Paul Taylor • May 26, 2023

Medtronic posts profit, sales growth in Q4, agrees to buy Korean diabetes patch maker

The company is “confident in delivering durable revenue growth in the year ahead” amid continued improvements in procedure volumes.

By Peter Green • May 25, 2023

Slump in medtech VC activity continues as inflation keeps investors on the sidelines

Investors struck deals worth $1.8 billion over the first three months of the year, down from $3.0 billion across the start of 2022.

By Nick Paul Taylor • May 25, 2023

Acurable prepares to challenge ResMed for sleep apnea diagnosis market

The company’s device records the sounds of the patient’s respiratory and cardiac functions and monitors blood oxygen levels to assess suspected obstructive sleep apnea.

By Nick Paul Taylor • May 25, 2023

FDA teams with Veterans Health Administration to make medtech supply chains more resilient

Rather than amassing reserves of physical supplies, “digital stockpiles” would create a network of trusted suppliers that have the ability to make products at or near the point of use. 

By Nick Paul Taylor • May 24, 2023

Integra recalls all devices made at Boston facility in the past 5 years, pauses production

Integra initiated the recall after an internal investigation found endotoxin testing deviations that can result in postoperative fevers. Analysts at BTIG said the recall raises “bigger questions” about Integra’s management.

By Nick Paul Taylor • May 24, 2023

‘Genuine bull market’ underway in medtech stocks, says CNBC’s Cramer

The “Mad Money” show host said shares of medical device companies stand to benefit from pent-up demand for surgeries postponed during the COVID-19 pandemic.

By Susan Kelly • Updated May 23, 2023

Orthopedic markets to return to normal this year as post-pandemic boost fades: analysts

Hip growth should normalize late this year, while the knee and spine markets are expected to slow down by the end of 2024, say analysts at Needham.

By Nick Paul Taylor • May 23, 2023

PulseAI algorithm beats Apple Watch software at detecting atrial arrhythmias

In a head-to-head comparison with Apple’s pre-installed software for interpreting ECG data, Pulse AI’s algorithm was better at detecting atrial arrhythmias. 

By Nick Paul Taylor • May 23, 2023

Vicarious, preparing to take on Intuitive in robotic surgery, names new COO

John Mazzola will oversee operations as Vicarious prepares to seek FDA approval for a robotic surgery system that would take on Intuitive Surgical’s market-leading da Vinci robot.

By Susan Kelly • May 22, 2023

Beta Bionics wins FDA nod to challenge Medtronic for automated insulin pump market

Beta Bionics’ device, aimed at people with Type 1 diabetes, has eliminated most of the data entry required by competitors.

By Nick Paul Taylor • May 22, 2023

Abbott, Boston Scientific, Medtronic share data on heart rhythm devices at conference

A series of recent innovations in pacemaker technology has opened up new markets and set the stage for increased competition.

By Nick Paul Taylor • May 22, 2023

A Boston Scientific purchase of Shockwave could be transformative — but at what price?

Boston Scientific has used “tuck-in” acquisitions to boost growth in the past. Some analysts say it should stay the course amid a report the company may make a bid.

By Susan Kelly • May 19, 2023

Precision Lens ordered to pay $487M for kickbacks to eye surgeons in Medicare false-claims case

Luxury vacations and tickets to Broadway shows were used by the Minnesota-based ophthalmologic supply company to induce surgeons to use its products, a federal court ruled. 

By Elise Reuter • May 19, 2023

Abbott gains edge over cardiac monitor rivals with FDA clearance of 6-year device

Rival devices sold by Biotronik, Boston Scientific and Medtronic have battery lives ranging from three to 4.5 years.

By Nick Paul Taylor • May 19, 2023

Chinese medtechs post data on renal denervation devices to rival Medtronic, ReCor

The findings validate the technique used by Medtronic and ReCor, while suggesting the U.S. companies will face competition if they target the Chinese market.

By Nick Paul Taylor • May 19, 2023

Abbott shares data showing benefit of TriClip device amid FDA review

Patients experienced a reduction in tricuspid regurgitation and had improved heart function, according to late-breaking data presented at EuroPCR.

By Elise Reuter • May 18, 2023

J&J names Jasmina Brooks as president of Biosense Webster

Brooks will lead the company as J&J competes with rivals such as Boston Scientific over cardiac ablation technology.

By Nick Paul Taylor • May 18, 2023

Clinical trials showcase potential roles for ultrasound in treating cancer, inflammatory disease

The use of ultrasound as a therapeutic device could lead to new treatment options. In one study, patients with brain tumors received an ultrasound implant that allowed a drug to enter the brain.

By Nick Paul Taylor • May 18, 2023